Cargando…
Effect of add-on alpha lipoic acid on psychopathology in patients with treatment-resistant schizophrenia: a pilot randomized double-blind placebo-controlled trial
RATIONALE: Alpha lipoic acid is known to reverse NMDA receptor hypofunction in addition to dopamine receptor blockade activity. It also enhances neurotrophic factors and has antioxidant potential. These properties combined together may be beneficial for treatment-resistant schizophrenia (TRS). OBJEC...
Autores principales: | Mishra, Archana, Reeta, K. H., Sarangi, Sudhir Chandra, Maiti, Rituparna, Sood, Mamta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449282/ https://www.ncbi.nlm.nih.gov/pubmed/36069950 http://dx.doi.org/10.1007/s00213-022-06225-2 |
Ejemplares similares
-
Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid
por: Li, Chun-jun, et al.
Publicado: (2012) -
Hypotensive effect of alpha-lipoic acid after a single administration in rats
por: Dudek, Magdalena, et al.
Publicado: (2016) -
EEG ALPHA COHERENCE AND PSYCHOPATHOLOGICAL DIMENSIONS OF SCHIZOPHRENIA
por: John, John P., et al.
Publicado: (2002) -
Effect of Haloperidol and Risperidone on Serum Melatonin and GAP-43 in Patients with Schizophrenia: A Prospective Cohort Study
por: Maiti, Rituparna, et al.
Publicado: (2021) -
Innovations in the Management of Musculoskeletal Pain With Alpha-Lipoic Acid (IMPALA Trial): Study protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of Alpha-Lipoic Acid for the Treatment of Fibromyalgia Pain
por: Gilron, Ian, et al.
Publicado: (2017)